HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

9-norbornyl-6-chloropurine

structure in first source

Also Known As:

9-((1R*,2R*,4S*)-bicyclo(2.2.1)hept-2-yl)-6-chloro-9H-purine; NCP compound.

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - 9-norbornyl-6-chloropurine: 1

Experts

1.	Dejmek, Milan: 1 article (01/2016)
2.	Hřebabecký, Hubert: 1 article (01/2016)
3.	Mertlíková-Kaiserová, Helena: 1 article (01/2016)
4.	Nencka, Radim: 1 article (01/2016)
5.	Neyts, Johan: 1 article (01/2016)
6.	Plačková, Pavla: 1 article (01/2016)
7.	Thibaut, Hendrik-Jan: 1 article (01/2016)
8.	Šmídková, Markéta: 1 article (01/2016)
9.	Šála, Michal: 1 article (01/2016)

Related Diseases

1.	Mitochondrial Diseases (Mitochondrial Disease) 01/01/2016 - "9-Norbornyl-6-chloropurine (NCP) induces cell death through GSH depletion-associated ER stress and mitochondrial dysfunction."
2.	Leukemia 01/01/2016 - "9-Norbornyl-6-chloropurine (NCP) is a representative of a series of antienteroviral bicycle derivatives with selective cytotoxicity towards leukemia cell lines. "